| | Class 2 Device Recall KIT, PRE OP DRAH |  |
| Date Initiated by Firm | July 30, 2020 |
| Create Date | September 25, 2020 |
| Recall Status1 |
Terminated 3 on April 28, 2021 |
| Recall Number | Z-3016-2020 |
| Recall Event ID |
86178 |
| Product Classification |
Tray, surgical - Product Code LRP
|
| Product | KIT, PRE OP DRAH - Product Usage: Preoperative kit used to decolonize intranasal S. aureus. |
| Code Information |
Model: ORPDH5994A Lot numbers: 558357, 561502,566549, 571467, 574058. Expiration dates: Varies by kit components. |
| FEI Number |
3002973487
|
Recalling Firm/ Manufacturer |
Cardinal Health 200, LLC 785 Fort Mill Hwy Fort Mill SC 29707-7555
|
| For Additional Information Contact | Josh Diercks 803-802-6800 |
Manufacturer Reason for Recall | Only providing one nasal swab in our pre-operative kit instead of the 4 required for proper treatment. |
FDA Determined Cause 2 | Employee error |
| Action | On July 30th the firm send its consignee a letter notifying them of the field action.
Component Part Number: X12048 (SWABSTICK, PVP-I,10%, NASAL DECOLONIZATION, PROFEND,NS) is supplied to Cardinal Health, Presource in a package of 4 nasal swabs. Per the suppliers Instructions for Use, X12048 is a kit that needs to be administered in a 4-swab treatment with two swabs used per nasal passage. Presource is only providing one nasal swab in our pre-operative kit instead of the 4 required for proper treatment. The Presource kit was set up requiring 1 each of the swab component, but confusion in the component set-up caused 1 swab to be kitted instead of 1 package of 4 swabs. |
| Quantity in Commerce | 9,150 kits |
| Distribution | US Nationwide distribution including the state of North Carolina. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|